Laxaro

View the latest news and breaking news today

healthy trend: indian pharma firms see rise in usfda drug approvals in fy18

healthy trend: indian pharma firms see rise in usfda drug approvals in fy18 Article News With Simple Text and Web Resource Link. For View Full Content Click on Source Link on Then Bottom Of News.



healthy trend: indian pharma firms see rise in usfda drug approvals in fy18

as fy18 enters its final quarter, a look at formulation approvals by the us food and drug administration (fda) in the year till date (ytd) period shows an improvement over the last year. deepak malik, associate director at edelweiss securities, says that 750-800 approvals had come in 2016-17. in 2017-18, around 1,000 abbreviated new drug applications (andas) to fda are likely to get approval. "so far, around 700 or so approvals have come for andas, and the last quarter is expected to see another 300 or so," he said.  of the major companies that sell drugs in that country, ahmedabad-headquartered cadila healthcare (zydus) has received the largest number of approvals, at 76, so far in fy18. there were only 14 approvals for the...